Search Results - "Coss, Chris C"

Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats by Xie, Zhiliang, Chen, Min, Goswami, Swagata, Mani, Rajes, Wang, Dasheng, Kulp, Samuel K., Coss, Chris C., Schaaf, Larry J., Cui, Fengyu, Byrd, John C., Jennings, Ryan N., Schober, Karsten K., Freed, Carrie, Lewis, Stephanie, Malbrue, Raphael, Muthusamy, Natarajan, Bennett, Chad, Kisseberth, William C., Phelps, Mitch A.

“…In this study, we characterized the pharmacokinetics of OSU-2S, a fingolimod-derived, non-immunosuppressive phosphatase activator, in mice, rats, and dogs, as…”
Get full text

746 Cancer cachexia associated Fc receptor expression on leukocytes as potential mechanism of checkpoint inhibitor resistance in patients and in murine cancer models by Remaily, Bryan, Lathrop, Hannah, Thomas, Justin, Kim, Kyeongmin, Vu, Trang, Stanton, Camille, Manna, Millenium, Granchie, Lauren, Xie, Zhiliang, Guo, Yizhen, Owen, Dwight, Kulp, Samuel, Ganesan, Latha, Coss, Chris C, Phelps, Mitch, Mace, Thomas

“…BackgroundCancer cachexia is a multifactorial syndrome characterized by irreversible loss of skeletal muscle and adipose tissue resulting from increased…”
Get full text